Men’s Preventive Care

Prostate, testicular, CV screening, skin checks, and healthy aging basics.

  • 2 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Men’s Preventive Care


oncodaily.com > genitourinary-oncology > stamina

STAMINA Trial: Lifestyle Intervention Mitigates ADT-Associated Adverse Effects in Prostate Cancer

3+ hour, 44+ min ago   (843+ words) The study, titled “An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial,” was published online in The Lancet Oncology on September 4, 2026. Authors: Liam Bourke, Derek J Rosario,…...


andoveradvertiser.co.uk > news > 26548092.free-prostate-screening-abbotts-ann-september

Free prostate screening event to be held in Abbotts Ann

4+ hour, 31+ min ago   (238+ words) One of the most commonly diagnosed cancers in UK men will be addressed at a free prostate screening event in Abbotts Ann. The Prostate Project will visit Abbotts Ann War Memorial Hall on September 26, from 11am to 3pm. Eligible men can receive…...


floridaweekly.com > articles > fort-myers-arts-and-entertainment-news > fort-myers > bonita-springs > prostate-cancer-screenings-are-less-invasive-now-go-get-one

Prostate cancer screenings are less invasive??? now go get one

5+ hour, 4+ min ago   (200+ words) Hands off my prostate. That was the consensus among men for decades. They dreaded even the thought of scheduling a digital rectal exam with a urologist or primary care physician. Many men skipped the screening altogether, opting to roll the…...


genomeweb.com > business-news > regulatory > ce-mark > ce-ivdr > gnw-amoydx-ivdr-prostate-cancer-20260915

Amoy Diagnostics Prostate Cancer Panel Gets IVDR Certification as Olaparib Companion Diagnostic

6+ hour, 12+ min ago   (25+ words) GenomeWeb Amoy Diagnostics Prostate Cancer Panel Gets IVDR Certification as Olaparib Companion Diagnostic...


newsroom.ocfl.net > 2026 > 09 > know-your-numbers-why-im-sharing-my-prostate-cancer-journey

Know Your Numbers: Why I'm Sharing My Prostate Cancer Journey

6+ hour, 45+ min ago   (389+ words) By Orange County Mayor Jerry L. Demings September is National Prostate Cancer Awareness Month, a time to raise awareness about one of the most common cancers affecting men. This year, the observance carries special meaning for me because earlier this year,…...


kiprinform.com > en > news > health-minister-urges-men-to-discuss-prostate-cancer-screening-with-doctors

Health minister urges men to discuss prostate cancer screening with doctors – Cyprus Inform

10+ hour, 24+ min ago   (276+ words) Health Minister Neophytos Charalambides urged men to seek medical advice on prostate cancer screening, citing 726 new cases recorded annually in Cyprus. Nicosia, Cyprus. Health Minister Neophytos Charalambides called on men to seek medical advice on prostate cancer screening during a…...


cyprus-mail.com

Health minister urges men to seek early prostate cancer screening

10+ hour, 30+ min ago   (243+ words) Health Minister Neophytos Charalambides called on men to seek medical advice on prostate cancer screening. Speaking at the Europa Uomo event marking European prostate cancer awareness day on Tuesday, Charalambides said prostate cancer remained “accompanied by embarrassment, fear, or the…...


urotoday.com > video-lectures > mhspc > video > 5876-biomarker-selection-in-apmn-prostate-cancer-himisha-beltran-joshua-lang.html

Biomarker selection in APMN Prostate Cancer - Himisha Beltran & Joshua Lang

19+ hour, 10+ min ago   (964+ words) Himisha Beltran and Joshua Lang discuss biomarker testing for newly diagnosed metastatic prostate cancer. Both agree BRCA2 alterations offer the strongest, most reproducible signal for upfront PARP inhibitor therapy, while genes such as ATM warrant a risk-benefit discussion. Dr. Lang cautions…...


app.dealroom.co > news > note > janux-doses-first-patient-in-phase-1-trial-of-prostate-cancer-immunotherapy-janx013

Dealroom.co | Janux doses first patient in Phase 1 trial of prostate cancer immunotherapy JANX013

14+ hour, 9+ min ago   (257+ words) Janux doses first patient in Phase 1 trial of prostate cancer immunotherapy JANX013 Dealroom Janux doses first patient in Phase 1 trial of prostate cancer immunotherapy JANX013 What's happened: On 14 September 2026, Janux Therapeutics, a clinical-stage biotechnology company based in San Diego, announced that the…...